Effect of amlodipine pretreatment on ischaemia-reperfusion-induced increase in cardiac endothelin-1 binding site density

J Cardiovasc Pharmacol. 1992 Sep;20(3):416-20. doi: 10.1097/00005344-199209000-00011.

Abstract

Endothelin-1 (ET-1) may be implicated in the pathophysiology of myocardial ischaemia. To determine whether the long-acting calcium antagonist amlodipine attenuates the ischaemia- and reperfusion-induced increase in cardiac ET-1 binding sites, hearts from rats pretreated with amlodipine (0.25 or 0.5 mg/kg) 2 or 5 h before they were killed were made ischaemic for 20 or 40 min, reperfused, and subfractionated. Twenty- and 40-min ischaemia caused a time-dependent increase in ET-1 binding site density (Bmax) identified with [125I]ET-1. Amlodipine pretreatment attenuated this increase in a time- and dose-dependent manner. 0.25 and 0.5 mg/kg amlodipine also suppressed the reperfusion-induced increase in [125I]ET-1 binding site density, even when the 0.5-mg/kg pretreatment series reperfusion was administered after 40-min ischaemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amlodipine / pharmacology*
  • Animals
  • Calcium Channel Blockers / pharmacology*
  • Endothelins / metabolism*
  • Female
  • In Vitro Techniques
  • Myocardial Reperfusion Injury / metabolism*
  • Rats
  • Rats, Inbred WKY
  • Receptors, Endothelin / drug effects
  • Receptors, Endothelin / metabolism*

Substances

  • Calcium Channel Blockers
  • Endothelins
  • Receptors, Endothelin
  • Amlodipine